Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects (good and bad) the combination of
carboplatin and pemetrexed have on patients with recurrent ovarian, peritoneal, or fallopian
tube cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital